2018 Departmental Highlights
Michael Metro, MD, Associate Professor, Clinical Urology, Director, Reconstructive Urology, Temple University Hospital, will be a Visiting Professor at Urology Grand Rounds on Friday, December 7, 2018 at 7:00 AM in the Weiler Auditorium, Einstein Campus. Dr. Metro's clinical interests include urethral stricture disease, Peyronie's disease, male stress urinary incontinence, erectile dysfunction, genitourinary trauma and genitourinary reconstruction.
Dr. Metro will present "Urethroplasty 101 and 202."
Beth Drzewiecki, MD, Pediatric Urology, and Robert Beil, MD, Medical Director, Transgender Program, both participated in the 2018 Community Health Network Conference on Transgender Health. The conference, held in New York City on October 18-19, focused on a range of health issues facing the transgender community. Dr. Drzewiecki participated in a panel discussion on “TRANSitioning: From Pre-Surgical to Post-Surgical care.
Joshua Stern, MD, Director of Endourology and the Kidney Stone Clinic, received a $100,000 grant from the NIDDK-sponsored Diabetic Complications Consortium which is sponsored by the National Institutes of Health (NIH). The grant will help fund his study, "Can the Gut Microbiome Influence Urinary Stone Disease in the Diabetic Population?" The study, which focuses on the role that the gut microbiome has on kidney stone risk in patients, is a follow-up to a previous NIH-funded study Dr. Stern conducted.
Richard C. Rink, MD, Emeritus Professor, Pediatric Urology, and Surgical Director, CARES Comprehensive Care Center, Indiana University Medical Center, will be a Visiting Professor at Urology Grand Rounds on Friday, September 21, 2018 at 7:00 AM in the Weiler Auditorium, Einstein Campus. Dr. Rink's main interests are reconstruction of congenital anomalies of the genitalia and the lower urinary tract. He is widely known for his work in the use of gastrointestinal segments in genitourinary reconstruction and reconstruction of ambiguous genitalia and cloacal anomalies.
Dr. Rink will present "30 Years of Lower Urinary Reconstruction at Indiana: Things I Thought I Knew Then, Things I Think I Know Now."
Montefiore Urology hosted guest lecturer Randi Epstein, MD, MPH, Adjunct Professor, Columbia University, on Friday, September 14, 2018. Dr. Epstein presented "Aroused: The History of Hormones and How They Control Just About Everything" during Urology Grand Rounds.
Montefiore Urology recently received grant funding to participate in an exciting new research study on bladder cancer. The CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer study will compare bladder removal with medical therapy.
Members of the Montefiore Urology Department, along with researchers from our Albert Einstein College of Medicine, recently published a study that found urinary stone disease (USD) in adults is associated with an increased likelihood of asthma.
The study, led by Justin Lee, MD, Einstein, Nephrology, analyzed data from over 20,000 individuals aged 20 years or older who participated in the National Health and Nutrition Examination Survey (NHANES) 2007-2014. Montefiore-Einstein researchers and physicians contributed to the study, including Matthew Abramowitz, MD, Beth Drzewiecki, MD, Michal Melamed, MD, and Joshua Stern, MD. The study was published in European Urology Focus.
To read the study, click here.
Mark Schoenberg, MD, Chair, Urology, recently co-wrote a book, "Bladder Cancer: A Patient-Friendly Guide to Understanding Your Diagnosis and Treatment Options." The book was a unique collaboration between Dr. Schoenberg and a patient of his, David Pulver, who was diagnosed with bladder cancer in 2007. The book addresses the questions, concerns, and challenges that confront people diagnosed with bladder cancer by combining expert medical information with a clear and concise writing style.
The Department of Urology recently celebrated the graduation of its 2018 class of residents. At the celebration, Saman Moazami, MD, and Abhishek Srivastava, MD, Chief Residents, were honored for their contributions and achievements. Congratulations to Dr. Moazami and Dr. Srivastava!
Melissa Laudano, MD, recently spoke to BronxNet about the treatment of common urinary complaints in both men and women. Dr. Laudano highlighted the services and treatments offered by Montefiore Urology, and the exciting research underway in the department.
To view Dr. Laudano's interview, visit https://bit.ly/2Ivhuyv.
Joshua Stern, MD was recently promoted within the department of Urology to Director of Endourology and the Kidney Stone Clinic.
Notably, Dr. Stern will also be presenting at the upcoming Research on Calculus Kinetics (R.O.C.K.) Society meeting in Rochester, NY on Saturday, April 14, 2018. The meeting is a specialty, invitation only meeting of kidney stone experts nationwide. Dr. Stern will give his presentation, Influence of the Gut Microbiome on Urinary Stone Disease Risk.
To learn more about Dr. Stern’s research, visit his profile.
The Urology research team at Montefiore and Einstein was ranked 16th in total 2017 National Institutes of Health (NIH) funding in the field of Urology by the Blue Ridge Institute for Medical Research, up from 23rd in 2016. Overall, investigators at Einstein and Montefiore secured $174 million from the NIH in the federal fiscal year 2017. Einstein ranks 7th in award dollars per investigator among the nation's top medical schools.
Guillermo Villegas, a post-doctoral fellow in the Laboratory of Kelvin Davies, PhD, recently won the best poster prize in the pre-clinical category at the International Society for Sexual Medicine meeting in Lisbon, Portugal. The poster, titled " Neuropraxia following nerve sparing radical prostatectomy is associated with increased expression of markers of inflammation and Fidgetin-2 like protein," was co-authored by Moses Tar, MD, Lisa Baker, David Sharp, PhD, and Kelvin Davies, PhD.
David Goldfarb, MD, Professor of Medicine and Physiology, NYU School of Medicine, and Interim Chief, Nephrology Division, NYU Langone Health, presented at Urology Grand Rounds on Friday, March 2, 2018 in the Weiler Auditorium, Einstein Campus. Dr. Goldfarb is committed to patient care, teaching and kidney stone research, at NYU.
Dr. Goldfarb presented "Update on Nephrolithiasis" at 7:00 AM. He currently serves on the Medical Advisory Board of the National Kidney Foundation, the Scientific Advisory Board of the Oxalosis and Hyperoxaluria Foundation, and Board of Directors of the International Cystinuria Foundation. Dr. Goldfarb is the principal investigator of the "Rare Kidney Stone Consortium's Cystinuria Project," funded by the NIH.